Vaccines
Studies from Beckman Research Institute, Division of Virology further understanding of vaccines
Published in Vaccine Weekly, August 6th, 2008
Research findings, 'A fusion protein of HCMV IE1 exon4 and IE2 exon5 stimulates potent cellular immunity in an MVA vaccine vector,' are discussed in a new report. "A therapeutic CMV vaccine incorporating an antigenic repertoire capable of eliciting a cellular immune response has yet to be successfully implemented for patients who already have acquired an infection. To address this problem, we have developed a vaccine candidate derived from modified vaccinia Ankara (MVA) that expresses three immunodominant antigens (pp65, IE1, IE2) from CMV," scientists writing in the journal Virology report.
"The novelty of this vaccine is the fusion of two adjacent exons from...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2008-08-06)
More Articles from Vaccine Weekly
- Massachusetts General Hospital
Viral recombination another way HIV fools the immune system - Norwegian Institute of Public Health
Vaccinated infants well-protected against severe pneumococcal infection in Norway - Springer
Can tomatoes carry the cure for Alzheimer's? - University of Montreal
Identification of protein able to stimulate production of T-cells - Artificial Chromosomes
Data on artificial chromosomes described by researchers at Virginia Commonwealth University, Medical Department - Chlamydia
AlphaVax Announces Initiation of Chlamydia Vaccine Program - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
